fda drug shortage list tirzepatide Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the GLP-1 Drugs: FDA Sued Over

A 0.05% serum on needled skin delivers the equivalent of 0.5% on intact skin

Orforglipron may be particularly suitable for individuals who: Prefer daily pills over injections Travel frequently or want a treatment without refrigeration Struggle with needle confidence Want a simpler routine for long-term use The convenience factor is one of the strongest reasons healthcare professionals are watching the Eli Lilly weight-loss study closely

The medication is self-injected subcutaneously once a week, and any questions about dosing or side effects are handled through messages with the provider

These unique promoters have high tissue stage-specificity (38)